Fresenius | FRE - تكلفة المبيعات





تكلفة المبيعات تغيير تاريخ
Akzo Nobel EUR 1.5B 95M 2026-06
Alcon AG USD 1.18B 26M 2026-03
AstraZeneca USD 2.52B 2.73B 2026-06
BASF EUR 12.87B 1.01B 2026-06
Bayer EUR 5.23B 731M 2026-03
Beiersdorf EUR 2.06B 50M 2025-12
DaVita Healthcare Partners USD 2.52B 76.13M 2026-03
Demant DKK 2.89B 188M 2025-12
E.ON EUR 16.41B 114M 2026-03
Essilor EUR 5.55B 505M 2026-06
Fresenius EUR 4.4B 111M 2026-06
Fresenius Medical Care EUR 3.43B 248M 2026-03
Getinge SEK 3.97B 2.05B 2026-06
Givaudan CHF 2.07B 105M 2025-12
GlaxoSmithKline GBP 2.07B 192M 2026-06
GN Store Nord DKK 1.16B 1.08B 2026-03
GRIFOLS EUR 1.17B 90M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.07B 219M 2026-03
Novartis USD 3.71B 251M 2026-06
Philips EUR 2.21B 70M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
RWE EUR 3.21B 397M 2026-03
Sanofi EUR 3.02B 656M 2026-06
Smith & Nephew USD 901M 31M 2026-06